便利SOCRA CCRP｜正確的なCCRP問題数試験｜試験の準備方法Certified Clinical Research Professional (CCRP)トレーリング学習

Wiki Article

ちなみに、Tech4Exam CCRPの一部をクラウドストレージからダウンロードできます：https://drive.google.com/open?id=1YhEC74Etu5gWc8SwXuDRZ_CdWwleqqKk

CCRP準備資料は、資格認定の優れた支援者となります。 一度だけ試験をクリアできるように、世界中で高品質な認定CCRP学習ガイドを提供することに集中しています。 CCRP信頼性の高い試験ブートキャンプ資料には、PDFバージョン、ソフトテストエンジン、APPテストエンジンの3つの形式が含まれているため、当社の製品はさまざまな受験者の習慣を満たし、実際のCCRPテストのほぼ完全な質問と回答をカバーします。

Tech4Exam SOCRAのCCRP試験スタディガイドはあなたのキャリアの灯台になれます。Tech4Examは全ての受かるべきCCRP試験を含めていますから、Tech4Examを利用したら、あなたは試験に合格することができるようになります。これは絶対に賢明な決断です。恐い研究の中から逸することができます。Tech4Examがあなたのヘルパーで、Tech4Examを手に入れたら、半分の労力でも二倍の効果を得ることができます。

>> CCRP問題数 <<

SOCRA CCRPトレーリング学習 & CCRP認証資格

CCRP試験問題はグローバルなものであるとSOCRA誇らしく言えます。 したがって、どんな種類のCCRPテストトレントを求めても、当社のアフターサービスサービススタッフは、最も専門的な方法でCCRP練習問題の問題を解決するお手伝いをします。 CCRPのCertified Clinical Research Professional (CCRP)学習ツールを目指しているお客様は世界中のさまざまな国から来ており、間違いなく時間差があるため、CCRPトレーニングガイドで1日24時間、7日間、思いやりのあるTech4Examオンラインアフターサービスを提供します 週に数日、いつでもどこでも気軽にご連絡ください。

SOCRA CCRP 認定試験の出題範囲：

トピック出題範囲
トピック 1
  • Research Study Start-Up: This section of the exam measures the skills of Clinical Research Coordinators and covers the initial planning and setup of a clinical trial. It involves coordinating the development of the study protocol, ensuring it considers ethical guidelines and regulatory pathways like IND or IDE. It also includes creating essential study documents like informed consent forms and case report forms. The domain covers obtaining necessary approvals from stakeholders like the IRB and sponsor, selecting study sites, training staff, and ensuring the study's compliance with various laws. Additionally, it involves obtaining the research product and preparing all necessary tools and documentation for the study's commencement.|Research Study Implementation: This section of the exam measures the skills of Clinical Research Associates and covers the active management and execution of the clinical trial. It focuses on following the study protocol and standard operating procedures, managing the investigational product, and ensuring ongoing regulatory compliance. The domain includes identifying, documenting, and reporting any study anomalies such as adverse events or protocol deviations. It also involves managing subject recruitment, consent, and retention, as well as maintaining all study records and essential documents. Furthermore, it covers communicating with all study stakeholders and participating in study audits to ensure quality and adherence to regulations.
トピック 2
  • Research Study Closure: This section of the exam measures the skills of Clinical Research Coordinators and covers the activities required to properly conclude a clinical trial. It involves participating in the study closeout visit to verify documentation and account for the investigational product. The domain also includes developing and submitting final closure reports to the IRB, study sponsor, regulatory authorities, and clinicaltrials.gov. Finally, it covers the procedures for archiving study records.

SOCRA Certified Clinical Research Professional (CCRP) 認定 CCRP 試験問題 (Q26-Q31):

質問 # 26
A Phase I study of a new blood pressure medication has been submitted for initial approval to an IRB/IEC. In accordance with the CFR, the IRB/IEC must consider which of the following criteria when determining whether to approve the study?

正解：D

解説：
When reviewing protocols, IRBs/IECs are primarily responsible forsafeguarding human subjectsby evaluating risks, benefits, and fairness in subject selection.
* 21 CFR 56.111(a)(3):"In making its determination the IRB shall determine that... selection of subjects is equitable."
* 45 CFR 46.111(a)(3):Repeats this requirement, emphasizing fairness across gender, race, age, and socioeconomic status.
Other options:
* Patient population availability (A) is afeasibility issue, addressed by investigators and sponsors, not IRBs.
* Education of the study team (C) is confirmed by thesponsor and investigator, not IRB.
* Funding sources (D) may raise conflict of interest concerns, but they are not IRB approval criteria per federal regulations.
Thus, IRBs focus onjustice and fairness in subject selectionas part of the Belmont Report principles.
References:
21 CFR 56.111(a)(3).
Belmont Report (Justice principle).


質問 # 27
For a study with a significant risk investigational medical device that could optimize the effects of radiation therapy on cancer tumors, the investigational plan states mild burns are an anticipated effect. One subject developed severe burns with blistering. In accordance with the CFR, this effect must be reported to the sponsor and the IRB/IEC as soon as possible and at most how long after the investigator first learns of the effect?

正解：B

解説：
In device trials,unanticipated adverse device effects (UADEs)must be promptly reported.
* 21 CFR 812.150(a)(1):"An investigator shall submit to the sponsor and the reviewing IRB a report of anyunanticipated adverse device effectas soon as possible, but in no event later than10 working days after the investigator first learns of the effect." In this case,severe burns with blisteringgo beyond the anticipated effect of mild burns listed in the investigational plan. Therefore, it qualifies as aUADEand triggers expedited reporting. Options A, B, and C are too short; the regulation specifically mandates a10 working day maximumtimeframe.
Thus, the correct answer isD (10 working days).
References:
21 CFR 812.150(a)(1) (Reporting requirements for investigators).


質問 # 28
An investigator received $60,000 equity interest three years after study completion. What is the financial reporting requirement?

正解：A

解説：
* 21 CFR 54.4(b):Requires disclosureduring the study and for 1 year after completion.
* After three years, no disclosure is required.
References:21 CFR 54.4(b).


質問 # 29
Why would a Phase IV study be conducted?

正解：C

解説：
Phase IV studies (post-marketing) examine real-world safety and effectiveness.
* ICH E8(R1):Describes Phase IV as "studies performed after drug approval to delineate additional information including the drug's risks, benefits, and optimal use."
* They often test drugs innew or broader populationsbeyond original approval.
While dosing and schedules are Phase I-III, Phase IV focuses onnew patient populationsor long-term outcomes.
References:ICH E8(R1).


質問 # 30
A subject was instructed to do a glucose check 4 times a day for 10 days using an investigational glucose meter. The meter requires one new glucose test strip for each test. The subject received the meter along with
45 glucose test strips. How many unused test strips should the subject have after the 10 days?

正解：A

解説：
This is adrug/device accountability calculation question, testing compliance with investigational product tracking.
* The subject was instructed to perform4 glucose checks per day.
* Over10 days, that equals40 tests (4 × 10 = 40).
* Each test requires1 strip, so40 strips used.
* Subject was given45 strips, leaving5 unusedafter 10 days.
Investigators are responsible for maintaining accurate device/product accountability.
* ICH E6(R2) 4.6.3:"The investigator/institution should maintain records of the product's delivery to the trial site, the inventory, the use by each subject, and the return to the sponsor or alternative disposition."
* This ensures monitoring can confirm that product/device use aligns with the protocol and subject adherence.
Thus, the correct answer isB (5 unused test strips).
References:
ICH E6(R2), §4.6.3 (Investigational product accountability).


質問 # 31
......

今働いている受験者たちは悩んでいるのでしょう。時間と精力の不足を感じますか？CCRP試験は重要な試験だから、十分の時間と精力を利用して試験を準備します。弊社の問題集は質高いので、お客様はTech4ExamのCCRP問題集を利用したら、少ない時間と精力で試験に気楽に合格することができます。躊躇わずに我々のCCRP問題集を購入してください。

CCRPトレーリング学習: https://www.tech4exam.com/CCRP-pass-shiken.html

2026年Tech4Examの最新CCRP PDFダンプおよびCCRP試験エンジンの無料共有：https://drive.google.com/open?id=1YhEC74Etu5gWc8SwXuDRZ_CdWwleqqKk

Report this wiki page